Integrichain Blog

Blog

orphan drug

Contracts & Pricing Nick Iaconi Jui Andhare
February 27, 2023

FDA Set to Apply Orphan-Drug Exclusivity, 2022 Employer Health Benefits Survey...

5 Minute Read

Updates on two significant regulatory topics, including the FDA decision on orphan-drug exclusivity regulations and highlights from the Kaiser Family Foundation 2022 Employer Benefits Survey.

Pharma market access strategy for pre and post launch

Launch Readiness Rupal Patel
February 7, 2023

Perspectives on Pharma Market Access Launch Challenges & Strategy Part 1

5 Minute Read

We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.

pharmaceutical pricing strategy reporting

Contracts & Pricing Carter Hall Brian Bumpus Sarah Vo
January 31, 2023

Inflation Reduction Act Impact on R&D, OIG Studies on Average Sales...

6 Minute Read

Updates on four significant regulatory topics, including the inflation reduction act impact on research and development, Office of Inspector General studies on Average Sales Price, and a shift of...

Pharmaceutical distribution channel analytics

Channel Dave Weiss
January 10, 2023

Direct Selling as a Distribution Channel for Specialty Lite Pharmaceuticals

3 Minute Read

Insights into specialty lite challenges and a new channel strategy that has emerged to help manufacturers balance patient access with their gross-to-net.

pharmaceutical pricing strategy reporting

Contracts & Pricing Carter Hall Michael Gorokhovsky Olivia Nweze
December 20, 2022

Value-Based Purchasing, Interchangeability in Biosimilars, Year End 2022 Roundup

5 Minute Read

Updates on two significant regulatory topics, including value-based purchasing, interchangeabilty with biosimilars, and an end of 2022 roundup.

Capitol Building, where state price transparency laws are enacted

Contracts & Pricing John Whitridge
December 15, 2022

2022 Trends in State Pricing Transparency Reporting

3 Minute Read

This is the first in a two-part blog series covering the ever-changing requirements by states as well as 2022 trends in Pricing Transparency Reporting.

ICyte Platform Josh Halpern
December 1, 2022

Entering the New Era of Data-Driven Drug Commercialization

5 Minute Read

Co-Founder and Chief Operating Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization, highlighted at the Access Insights Conference...

Contracts & Pricing Nick Iaconi Olivia Nweze Victoria Nolan
November 23, 2022

Consumer Price Index, Pricing Transparency Updates, and the Impact of Digital...

5 Minute Read

Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.

Contracts & Pricing Nick Iaconi Brian Bumpus Carter Hall
October 27, 2022

Stacking Discounts for Best Price, PHS & 340B, HHS Ruling

3 Minute Read

Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article